The effect of exercise training and Camelina oil consumption on type 2 diabetes

The effect of 8 weeks of combined home-based exercise and Camelina oil consumption on insulin resistance, lipid profile, quality of life and some psychological indices in women with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210617051606N2

Enrollment

Registered

2021-09-13

Start date

2021-06-22

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group (Exercise + Camelina): this group performs combined home-based aerobic and bodyweight resistance training 3 times a week for 8 weeks. The intensity of aerobic and re

Eligibility

Sex/Gender

Female

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Not participation in regular exercise training over the last 6 months Having type 2 diabetes confirmed by specialist Fasting blood glucose of equal or more than 126 milligrams in deciliter to 400 milligrams in deciliter No insulin injection Getting the certification of no prohibition of participating in exercise training program from a specialist

Exclusion criteria

Exclusion criteria: Acute or chronic inflammatory diseases Heart diseases Pregnancy Alcohol and other kinds of drug addiction Musculoskeletal disorder Refusal to give informed consent

Design outcomes

Primary

Measure	Time frame
Changes in insulin resistance. Timepoint: Before starting the intervention, and 8 weeks after starting the intervention. Method of measurement: By blood sample and Hemostatic Model Assessment for Insulin Resistance (HOMA-IR). In this case, fasting blood insulin and glucose are measured and then, they will be put in the HOMA-IR formula.;Changes in fasting blood glucose. Timepoint: Before starting the intervention, and 8 weeks after starting the intervention. Method of measurement: By blood sample in fasting condition.;Changes in lipid profile. Timepoint: Before starting the intervention, and 8 weeks after starting the intervention. Method of measurement: By blood sample in fasting condition.;Change in quality of life. Timepoint: Before starting the intervention, and 8 weeks after starting the intervention. Method of measurement: World health organization standard quality of life questionnaire (short version).;Change in depression severity. Timepoint: Before starting the intervention, and 8 weeks after starting the intervention. Method of measurement: Hamilton Depression Rating Scale.	—

Measure

Time frame

Changes in insulin resistance. Timepoint: Before starting the intervention, and 8 weeks after starting the intervention. Method of measurement: By blood sample and Hemostatic Model Assessment for Insulin Resistance (HOMA-IR). In this case, fasting blood insulin and glucose are measured and then, they will be put in the HOMA-IR formula.;Changes in fasting blood glucose. Timepoint: Before starting the intervention, and 8 weeks after starting the intervention. Method of measurement: By blood sample in fasting condition.;Changes in lipid profile. Timepoint: Before starting the intervention, and 8 weeks after starting the intervention. Method of measurement: By blood sample in fasting condition.;Change in quality of life. Timepoint: Before starting the intervention, and 8 weeks after starting the intervention. Method of measurement: World health organization standard quality of life questionnaire (short version).;Change in depression severity. Timepoint: Before starting the intervention, and 8 weeks after starting the intervention. Method of measurement: Hamilton Depression Rating Scale.

—

Secondary

Measure	Time frame
Change in physical self-concept. Timepoint: Before intervention and after 8 weeks of intervention. Method of measurement: Physical self-concept questionnaire.;Change in the quality of sleep. Timepoint: Before intervention and after 8 weeks of intervention. Method of measurement: Pittsburgh Sleep Quality Index.;Change in anxiety. Timepoint: Before intervention and after 8 weeks of intervention. Method of measurement: Beck Anxiety Inventory.;Change in self-esteem. Timepoint: Before intervention and after 8 weeks of intervention. Method of measurement: Rosenberg’s Self-Esteem Scale.	—

Measure

Time frame

Change in physical self-concept. Timepoint: Before intervention and after 8 weeks of intervention. Method of measurement: Physical self-concept questionnaire.;Change in the quality of sleep. Timepoint: Before intervention and after 8 weeks of intervention. Method of measurement: Pittsburgh Sleep Quality Index.;Change in anxiety. Timepoint: Before intervention and after 8 weeks of intervention. Method of measurement: Beck Anxiety Inventory.;Change in self-esteem. Timepoint: Before intervention and after 8 weeks of intervention. Method of measurement: Rosenberg’s Self-Esteem Scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Amiri

Razi University

e.amiri@razi.ac.ir+98 83 3845 8428

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026